Shionogi
Clinical trials sponsored by Shionogi, explained in plain language.
-
Hope for rare brain disorder: new drug trial underway
Disease control OngoingThis study tests a drug called zatolmilast in 30 people aged 9 to 45 with Jordan's syndrome, a rare genetic condition affecting brain development. The main goal is to check if the drug is safe and tolerable. Participants will receive either the drug or a placebo, and researchers …
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated May 17, 2026 03:45 UTC
-
New stroke drug shows promise in major trial
Disease control OngoingThis study tests an experimental drug called redasemtide in 680 adults who have had a stroke caused by a blocked blood vessel. Participants receive either the drug or a placebo within 25 hours of their stroke. The goal is to see if the drug helps people recover better and have le…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated May 17, 2026 03:40 UTC
-
New drug combo aims to quiet Night-Time breathing pauses in sleep apnea patients
Symptom relief OngoingThis study tests three different drugs—sivopixant, acetazolamide, and SASS-001—to see if they can reduce breathing pauses during sleep in adults with sleep apnea that involves a central (brain-related) component. About 60 participants with stable heart failure or persistent atria…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC